These findings indicate that the combined evaluation of of MMP-9 and VEGF-C expression and lymphatic vessel characteristics is useful in predicting the probability of malignant metastasis and can also provide theoretical guidance for the clinical treatment of breast cancer patients. The gene discussed is VEGFC; the disease is breast carcinoma.